Impact of ranolazine on ventricular arrhythmias – A systematic review

Impact of ranolazine on ventricular arrhythmias – A systematic review

Abstract Ranolazine is a new medication for the treatment of refractory angina. However, except its anti‐anginal properties, it has been found to act as an anti‐arrhythmic. The aim of our systematic review is to present the existing data about the impact of ranolazine in ventricular arrhythmias. We...

Full description

Bibliographic Details
Main Authors: George Bazoukis, Gary Tse, Konstantinos P. Letsas, Costas Thomopoulos, Katerina K. Naka, Panagiotis Korantzopoulos, Xenophon Bazoukis, Paschalia Michelongona, Stamatis S. Papadatos, Konstantinos Vlachos, Tong Liu, Michael Efremidis, Adrian Baranchuk, Stavros Stavrakis, Costas Tsioufis
Format: Article
Language:English
Published: Wiley 2018-04-01
Series:Journal of Arrhythmia
Subjects:
anti‐arrhythmic drugs
ranolazine
ventricular arrhythmias
ventricular fibrillation
ventricular tachycardia
Online Access:https://doi.org/10.1002/joa3.12031

Internet

https://doi.org/10.1002/joa3.12031

Similar Items